thioridazine has been researched along with dicloxacillin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kallipolitis, BH; Klitgaard, JK; Kolmos, HJ; Nielsen, A; Olsen, A; Poulsen, MØ; Schøler, L; Skov, MN | 1 |
| Bollen, P; Hendel, K; Klitgaard, JK; Kolmos, HJ; Licht, PB; Stenger, M | 1 |
| Alm, M; Andersen, TE; Grønnemose, RB; Klein, K; Klitgaard, JK; Kolmos, HJ; Lindholt, JS; Stenger, M; Thomsen, P | 1 |
| Jacobsen, K; Kallipolitis, BH; Klitgaard, JK; Kolmos, HJ; Poulsen, MØ; Rasmussen, KS; Skov, MN | 1 |
| Andersen, TE; Behr-Rasmussen, C; Grønnemose, RB; Klein, K; Klitgaard, JK; Kolmos, HJ; Lindholt, JS; Stenger, M | 1 |
| Kallipolitis, BH; Klitgaard, JK; Kolmos, HJ; Lauritzen, SP; Lund, LC; Thorsing, M; Wassmann, CS | 1 |
1 review(s) available for thioridazine and dicloxacillin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for thioridazine and dicloxacillin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Combination therapy with thioridazine and dicloxacillin combats meticillin-resistant Staphylococcus aureus infection in Caenorhabditis elegans.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Caenorhabditis elegans; Dicloxacillin; Disease Models, Animal; Drug Therapy, Combination; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Thioridazine; Treatment Outcome | 2014 |
Assessments of Thioridazine as a Helper Compound to Dicloxacillin against Methicillin-Resistant Staphylococcus aureus: In Vivo Trials in a Mouse Peritonitis Model.
Topics: Animals; Anti-Bacterial Agents; Dicloxacillin; Disease Models, Animal; Doublecortin Protein; Female; Methicillin-Resistant Staphylococcus aureus; Mice; Peritonitis; Staphylococcal Infections; Thioridazine | 2015 |
Co-release of dicloxacillin and thioridazine from catheter material containing an interpenetrating polymer network for inhibiting device-associated Staphylococcus aureus infection.
Topics: Anti-Bacterial Agents; Catheter-Related Infections; Cross Infection; Dicloxacillin; Drug Delivery Systems; Drug Liberation; Polyhydroxyethyl Methacrylate; Polymers; Silicones; Staphylococcal Infections; Staphylococcus aureus; Thioridazine; Vascular Access Devices | 2016 |
Combination of thioridazine and dicloxacillin as a possible treatment strategy of staphylococci.
Topics: Anti-Bacterial Agents; Dicloxacillin; Dopamine Antagonists; Drug Synergism; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Thioridazine | 2017 |
Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity.
Topics: Animals; Body Temperature; Body Weight; Dicloxacillin; Disease Models, Animal; Drug Synergism; Female; Haptoglobins; Hemoglobins; Leukocyte Count; Staphylococcal Infections; Staphylococcus aureus; Swine; Thioridazine; Time Factors; Vascular Grafting | 2017 |
Molecular mechanisms of thioridazine resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cardiolipins; Dicloxacillin; Drug Resistance, Bacterial; Membrane Potentials; Membrane Proteins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Phylogeny; Thioridazine; Transferases (Other Substituted Phosphate Groups); Whole Genome Sequencing | 2018 |